MiNK Therapeutics
INKT
$0.89
Share price
-1.11%
Change (1 day)
-62.13%
Change (1 year)
Categories
MiNK Therapeutics (INKT) - P/B ratio
P/B ratio as of June 2024 : -1.73
According to MiNK Therapeutics's latest financial reports the company has a price-to-book ratio of -1.73.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
MiNK Therapeutics - P/B ratio (from 2021 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | N/A | -100% |
| 2023-12-31 | -2.05 | -99.07% |
| 2022-12-31 | -220 | -3596.35% |
| 2021-12-31 | 6.28 | |
| 2020-12-31 | N/A |